Skip to main content
Medigene AG logo

Medigene AG — Investor Relations & Filings

Ticker · MDG1 ISIN · DE000A40ESG2 LEI · 391200I33JD2DKZGDX06 F Professional, scientific and technical activities
Open in API
Filings indexed 114 across all filing types
Latest filing 2015-11-18 Interim / Quarterly Rep…
Country DE Germany
Listing F MDG1

About Medigene AG

https://medigene.com/

Medigene AG is a biotechnology company that develops T-cell receptor (TCR)-guided immunotherapies for the treatment of cancer. The company utilizes its proprietary End-to-End platform to discover and develop optimized 3S (sensitive, specific, safe) TCRs. These TCRs are designed for application across various therapeutic modalities, including TCR-T cell therapies, TCR-T cell engagers, and TCR-natural killer cell therapies, targeting different forms of cancer. A key clinical program is MDG1015, a third-generation TCR-T therapy targeting the NY-ESO-1/LAGE-1a antigen, which is enhanced with a PD1-41BB costimulatory switch protein. As of August 2025, the company is undergoing insolvency proceedings.

Recent filings

Filing Released Lang Actions
Datum:18.11.2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsfinanzbericht' (Quarterly Financial Report) for Medigene AG for the period ending September 30, 2015. It contains detailed financial data, including income statements, research and development costs, EBITDA analysis, and a comprehensive management discussion of the company's business segments and product portfolio. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2015
2015-11-18 German
Datum:29.09.2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for Medigene AG for the period ending June 30, 2015. It contains detailed financial data, including key performance indicators (Kennzahlen), income statements (Ertragslage), and management discussion of business activities. It is a comprehensive interim report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). H1 2015
2015-09-29 German
Datum:27.05.2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsfinanzbericht' (Quarterly Financial Report) for Medigene AG for the period ending March 31, 2015. It contains detailed financial highlights, key performance indicators (EBITDA, R&D expenses), and a comprehensive management discussion on the company's product portfolio and clinical trials. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2015
2015-05-27 German
Datum:30.04.2015
Annual Report Classification · 100% confidence The document is a comprehensive annual financial statement ('Jahresabschluss') for Medigene AG for the fiscal year 2014. It includes the balance sheet ('Bilanz'), profit and loss statement ('Gewinn- und Verlustrechnung'), notes to the financial statements ('Anhang'), and the auditor's report ('Bestätigungsvermerk'). As it contains full financial statements and is a formal annual reporting document, it is classified as an Annual Report (10-K). FY 2014
2015-04-30 German
Datum:29.01.2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTALSFINANZBERICHT ZUM 30. SEPTEMBER 2014' (Quarterly Financial Report as of September 30, 2014) and 'KONZERN-ZWISCHENBERICHT Q3-2014/9M-2014' (Consolidated Interim Report Q3-2014/9M-2014). It contains detailed financial highlights, operational updates, and management discussion for the nine-month period ending September 30, 2014. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2014
2015-01-29 German
Hinweis auf Quartalsfinanzbericht vom 01.01.2014 bis zum 30.09.2014
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that informs stakeholders about the availability of a quarterly financial report. It explicitly states 'Hinweis auf Quartalsfinanzbericht' (Notice regarding quarterly financial report) and provides a URL where the report can be accessed. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2014-10-16 German

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.